Skip to content

The curative effect of luteal phase ovarian stimulation for PCOS patients undergoing IVF procedure

Comparison of the treatment outcomes for PCOS patients undergoing IVF procedure using luteal phase ovarian stimulation vs. conventional ovarian stimulation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006490
Enrollment
Unknown
Registered
2015-06-02
Start date
2015-06-03
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

1:luteal phase ovarian stimulation protocol
2:GnRH agonist short protocol
3:GnRH antagonist protocol

Sponsors

Shanghai Ninth People's Hospital, Shanghai jiaotong university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 48 Years

Inclusion criteria

Inclusion criteria: These who meet the following three points will be included in the study: 1. Women who aged 20-48 years accept in vitro fertilization-embryo transfer treatment in assisted reproduction department of Shanghai Ninth People's Hospital during may to October in 2015; 2. Subjects will be in line with the 2003 Rotterdam criteria for the diagnosis of polycystic ovary syndrome; 3. Undergoing conventional IVF or ICSI treatment using the GnRH agonist short protocol, GnRH antagonist protocol and luteal phase ovarian stimulation.

Exclusion criteria

Exclusion criteria: A history of ovarian surgery or using of immunomodulators, cytokines and cytotoxic drugs in the three months before the treatment;Patients with a diagnosis of a primary diagnosis of another type of ovulatory infertility, hyperprolactinemia, endometriosis cysts, any kind of functional or organic ovarian cysts, uterine myoma or intrauterine adhesionswere excluded from this study; Repeated failure of artificial insemination, unexplained infertility or immune infertility patients; Rescue intracytoplasmic sperm injection; A history of serious organic disease.

Design outcomes

Primary

MeasureTime frame
Number of oocytes retrieved;Number of mature oocytes;Fertilization rate;Utilization of oocytes;Clinical pregnancy rate;Embryo implantation rate;

Countries

China

Contacts

Public ContactYanping Kuang
kuangyanp@126.com+86 135018800828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026